Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata

Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata

Background: Patients with severe alopecia areata (AA), including alopecia totalis (AT) and alopecia universalis (AU), are usually resistant to treatment. While tofacitinib is emerging as a promising therapy for severe AA, little is known about its efficacy and safety in Asians. Objectives: To evalua...

Full description

Bibliographic Details
Main Authors: Ying-Xiu Dai, Chen-Pu Yeh, Chih-Chiang Chen
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Dermatologica Sinica
Subjects:
alopecia areata
janus kinase inhibitor
tofacitinib
treatment
Online Access:http://www.dermsinica.org/article.asp?issn=1027-8117;year=2020;volume=38;issue=1;spage=3;epage=8;aulast=Dai

Internet

http://www.dermsinica.org/article.asp?issn=1027-8117;year=2020;volume=38;issue=1;spage=3;epage=8;aulast=Dai

Similar Items